000100062312/312025Q3FALSExbrli:sharesiso4217:USDiso4217:USDxbrli:sharesmatv:segmentxbrli:pureiso4217:EUR00010006232025-01-012025-09-3000010006232025-11-0300010006232025-07-012025-09-3000010006232024-07-012024-09-3000010006232024-01-012024-09-3000010006232025-09-3000010006232024-12-310001000623us-gaap:CommonStockMember2024-06-300001000623us-gaap:AdditionalPaidInCapitalMember2024-06-300001000623us-gaap:RetainedEarningsMember2024-06-300001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-3000010006232024-06-300001000623us-gaap:RetainedEarningsMember2024-07-012024-09-300001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001000623us-gaap:CommonStockMember2024-07-012024-09-300001000623us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001000623us-gaap:CommonStockMember2024-09-300001000623us-gaap:AdditionalPaidInCapitalMember2024-09-300001000623us-gaap:RetainedEarningsMember2024-09-300001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-3000010006232024-09-300001000623us-gaap:CommonStockMember2025-06-300001000623us-gaap:AdditionalPaidInCapitalMember2025-06-300001000623us-gaap:RetainedEarningsMember2025-06-300001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-3000010006232025-06-300001000623us-gaap:RetainedEarningsMember2025-07-012025-09-300001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-07-012025-09-300001000623us-gaap:CommonStockMember2025-07-012025-09-300001000623us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001000623us-gaap:CommonStockMember2025-09-300001000623us-gaap:AdditionalPaidInCapitalMember2025-09-300001000623us-gaap:RetainedEarningsMember2025-09-300001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001000623us-gaap:CommonStockMember2023-12-310001000623us-gaap:AdditionalPaidInCapitalMember2023-12-310001000623us-gaap:RetainedEarningsMember2023-12-310001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3100010006232023-12-310001000623us-gaap:RetainedEarningsMember2024-01-012024-09-300001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001000623us-gaap:CommonStockMember2024-01-012024-09-300001000623us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001000623us-gaap:CommonStockMember2024-12-310001000623us-gaap:AdditionalPaidInCapitalMember2024-12-310001000623us-gaap:RetainedEarningsMember2024-12-310001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001000623us-gaap:RetainedEarningsMember2025-01-012025-09-300001000623us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-09-300001000623us-gaap:CommonStockMember2025-01-012025-09-300001000623us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-300001000623country:USmatv:FAMSegmentMember2025-07-012025-09-300001000623country:USmatv:SASSegmentMember2025-07-012025-09-300001000623country:US2025-07-012025-09-300001000623country:USmatv:FAMSegmentMember2024-07-012024-09-300001000623country:USmatv:SASSegmentMember2024-07-012024-09-300001000623country:US2024-07-012024-09-300001000623srt:EuropeMembermatv:FAMSegmentMember2025-07-012025-09-300001000623srt:EuropeMembermatv:SASSegmentMember2025-07-012025-09-300001000623srt:EuropeMember2025-07-012025-09-300001000623srt:EuropeMembermatv:FAMSegmentMember2024-07-012024-09-300001000623srt:EuropeMembermatv:SASSegmentMember2024-07-012024-09-300001000623srt:EuropeMember2024-07-012024-09-300001000623srt:AsiaPacificMembermatv:FAMSegmentMember2025-07-012025-09-300001000623srt:AsiaPacificMembermatv:SASSegmentMember2025-07-012025-09-300001000623srt:AsiaPacificMember2025-07-012025-09-300001000623srt:AsiaPacificMembermatv:FAMSegmentMember2024-07-012024-09-300001000623srt:AsiaPacificMembermatv:SASSegmentMember2024-07-012024-09-300001000623srt:AsiaPacificMember2024-07-012024-09-300001000623matv:AmericasExcludingUnitedStatesMembermatv:FAMSegmentMember2025-07-012025-09-300001000623matv:AmericasExcludingUnitedStatesMembermatv:SASSegmentMember2025-07-012025-09-300001000623matv:AmericasExcludingUnitedStatesMember2025-07-012025-09-300001000623matv:AmericasExcludingUnitedStatesMembermatv:FAMSegmentMember2024-07-012024-09-300001000623matv:AmericasExcludingUnitedStatesMembermatv:SASSegmentMember2024-07-012024-09-300001000623matv:AmericasExcludingUnitedStatesMember2024-07-012024-09-300001000623matv:OtherForeignCountriesMembermatv:FAMSegmentMember2025-07-012025-09-300001000623matv:OtherForeignCountriesMembermatv:SASSegmentMember2025-07-012025-09-300001000623matv:OtherForeignCountriesMember2025-07-012025-09-300001000623matv:OtherForeignCountriesMembermatv:FAMSegmentMember2024-07-012024-09-300001000623matv:OtherForeignCountriesMembermatv:SASSegmentMember2024-07-012024-09-300001000623matv:OtherForeignCountriesMember2024-07-012024-09-300001000623matv:FAMSegmentMember2025-07-012025-09-300001000623matv:SASSegmentMember2025-07-012025-09-300001000623matv:FAMSegmentMember2024-07-012024-09-300001000623matv:SASSegmentMember2024-07-012024-09-300001000623country:USmatv:FAMSegmentMember2025-01-012025-09-300001000623country:USmatv:SASSegmentMember2025-01-012025-09-300001000623country:US2025-01-012025-09-300001000623country:USmatv:FAMSegmentMember2024-01-012024-09-300001000623country:USmatv:SASSegmentMember2024-01-012024-09-300001000623country:US2024-01-012024-09-300001000623srt:EuropeMembermatv:FAMSegmentMember2025-01-012025-09-300001000623srt:EuropeMembermatv:SASSegmentMember2025-01-012025-09-300001000623srt:EuropeMember2025-01-012025-09-300001000623srt:EuropeMembermatv:FAMSegmentMember2024-01-012024-09-300001000623srt:EuropeMembermatv:SASSegmentMember2024-01-012024-09-300001000623srt:EuropeMember2024-01-012024-09-300001000623srt:AsiaPacificMembermatv:FAMSegmentMember2025-01-012025-09-300001000623srt:AsiaPacificMembermatv:SASSegmentMember2025-01-012025-09-300001000623srt:AsiaPacificMember2025-01-012025-09-300001000623srt:AsiaPacificMembermatv:FAMSegmentMember2024-01-012024-09-300001000623srt:AsiaPacificMembermatv:SASSegmentMember2024-01-012024-09-300001000623srt:AsiaPacificMember2024-01-012024-09-300001000623matv:AmericasExcludingUnitedStatesMembermatv:FAMSegmentMember2025-01-012025-09-300001000623matv:AmericasExcludingUnitedStatesMembermatv:SASSegmentMember2025-01-012025-09-300001000623matv:AmericasExcludingUnitedStatesMember2025-01-012025-09-300001000623matv:AmericasExcludingUnitedStatesMembermatv:FAMSegmentMember2024-01-012024-09-300001000623matv:AmericasExcludingUnitedStatesMembermatv:SASSegmentMember2024-01-012024-09-300001000623matv:AmericasExcludingUnitedStatesMember2024-01-012024-09-300001000623matv:OtherForeignCountriesMembermatv:FAMSegmentMember2025-01-012025-09-300001000623matv:OtherForeignCountriesMembermatv:SASSegmentMember2025-01-012025-09-300001000623matv:OtherForeignCountriesMember2025-01-012025-09-300001000623matv:OtherForeignCountriesMembermatv:FAMSegmentMember2024-01-012024-09-300001000623matv:OtherForeignCountriesMembermatv:SASSegmentMember2024-01-012024-09-300001000623matv:OtherForeignCountriesMember2024-01-012024-09-300001000623matv:FAMSegmentMember2025-01-012025-09-300001000623matv:SASSegmentMember2025-01-012025-09-300001000623matv:FAMSegmentMember2024-01-012024-09-300001000623matv:SASSegmentMember2024-01-012024-09-300001000623matv:FiltrationNettingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-07-012025-09-300001000623matv:FiltrationNettingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-07-012024-09-300001000623matv:FiltrationNettingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-01-012025-09-300001000623matv:FiltrationNettingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-01-012024-09-300001000623matv:AdvancedFilmsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-07-012025-09-300001000623matv:AdvancedFilmsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-07-012024-09-300001000623matv:AdvancedFilmsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-01-012025-09-300001000623matv:AdvancedFilmsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-01-012024-09-300001000623matv:TapesLabelsLinersMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-07-012025-09-300001000623matv:TapesLabelsLinersMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-07-012024-09-300001000623matv:TapesLabelsLinersMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-01-012025-09-300001000623matv:TapesLabelsLinersMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-01-012024-09-300001000623matv:PaperPackagingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-07-012025-09-300001000623matv:PaperPackagingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-07-012024-09-300001000623matv:PaperPackagingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-01-012025-09-300001000623matv:PaperPackagingMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-01-012024-09-300001000623us-gaap:HealthCareOtherMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-07-012025-09-300001000623us-gaap:HealthCareOtherMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-07-012024-09-300001000623us-gaap:HealthCareOtherMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-01-012025-09-300001000623us-gaap:HealthCareOtherMemberus-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-01-012024-09-300001000623us-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-07-012025-09-300001000623us-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-07-012024-09-300001000623us-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2025-01-012025-09-300001000623us-gaap:ProductConcentrationRiskMemberus-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember2024-01-012024-09-3000010006232022-12-2300010006232022-12-222022-12-220001000623us-gaap:SubsequentEventMember2025-11-040001000623us-gaap:SubsequentEventMember2025-11-050001000623us-gaap:NonrecourseMemberus-gaap:AssetPledgedAsCollateralWithoutRightMember2025-09-300001000623us-gaap:NonrecourseMemberus-gaap:AssetPledgedAsCollateralWithoutRightMember2024-12-310001000623us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-09-300001000623us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310001000623us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-09-300001000623us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-12-310001000623us-gaap:AccumulatedTranslationAdjustmentMember2025-09-300001000623us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310001000623us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-07-012025-09-300001000623us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-07-012024-09-300001000623us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-07-012025-09-300001000623us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-07-012024-09-300001000623us-gaap:AccumulatedTranslationAdjustmentMember2025-07-012025-09-300001000623us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-09-300001000623us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-09-300001000623us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300001000623us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-09-300001000623us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-09-300001000623us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-300001000623us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300001000623matv:FAMSegmentMember2024-12-310001000623matv:SASSegmentMember2024-12-310001000623matv:FAMSegmentMember2025-09-300001000623matv:SASSegmentMember2025-09-300001000623matv:FAMSegmentMember2024-10-010001000623matv:SASSegmentMember2025-03-010001000623us-gaap:CustomerRelationshipsMember2025-09-300001000623us-gaap:DevelopedTechnologyRightsMember2025-09-300001000623us-gaap:TradeNamesMember2025-09-300001000623us-gaap:NoncompeteAgreementsMember2025-09-300001000623us-gaap:PatentsMember2025-09-300001000623us-gaap:CustomerRelationshipsMember2024-12-310001000623us-gaap:DevelopedTechnologyRightsMember2024-12-310001000623us-gaap:TradeNamesMember2024-12-310001000623us-gaap:NoncompeteAgreementsMember2024-12-310001000623us-gaap:PatentsMember2024-12-310001000623us-gaap:OtherCurrentAssetsMember2025-09-300001000623us-gaap:OtherCurrentAssetsMember2024-12-310001000623us-gaap:OperatingSegmentsMemberus-gaap:EmployeeSeveranceMembermatv:FAMSegmentMember2025-07-012025-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:EmployeeSeveranceMembermatv:FAMSegmentMember2024-07-012024-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:EmployeeSeveranceMembermatv:FAMSegmentMember2025-01-012025-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:EmployeeSeveranceMembermatv:FAMSegmentMember2024-01-012024-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:OtherRestructuringMembermatv:FAMSegmentMember2025-07-012025-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:OtherRestructuringMembermatv:FAMSegmentMember2024-07-012024-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:OtherRestructuringMembermatv:FAMSegmentMember2025-01-012025-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:OtherRestructuringMembermatv:FAMSegmentMember2024-01-012024-09-300001000623us-gaap:OperatingSegmentsMembermatv:FAMSegmentMember2025-07-012025-09-300001000623us-gaap:OperatingSegmentsMembermatv:FAMSegmentMember2024-07-012024-09-300001000623us-gaap:OperatingSegmentsMembermatv:FAMSegmentMember2025-01-012025-09-300001000623us-gaap:OperatingSegmentsMembermatv:FAMSegmentMember2024-01-012024-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:EmployeeSeveranceMembermatv:SASSegmentMember2025-07-012025-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:EmployeeSeveranceMembermatv:SASSegmentMember2024-07-012024-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:EmployeeSeveranceMembermatv:SASSegmentMember2025-01-012025-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:EmployeeSeveranceMembermatv:SASSegmentMember2024-01-012024-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:OtherRestructuringMembermatv:SASSegmentMember2025-07-012025-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:OtherRestructuringMembermatv:SASSegmentMember2024-07-012024-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:OtherRestructuringMembermatv:SASSegmentMember2025-01-012025-09-300001000623us-gaap:OperatingSegmentsMemberus-gaap:OtherRestructuringMembermatv:SASSegmentMember2024-01-012024-09-300001000623us-gaap:OperatingSegmentsMembermatv:SASSegmentMember2025-07-012025-09-300001000623us-gaap:OperatingSegmentsMembermatv:SASSegmentMember2024-07-012024-09-300001000623us-gaap:OperatingSegmentsMembermatv:SASSegmentMember2025-01-012025-09-300001000623us-gaap:OperatingSegmentsMembermatv:SASSegmentMember2024-01-012024-09-300001000623us-gaap:MaterialReconcilingItemsMemberus-gaap:EmployeeSeveranceMember2025-07-012025-09-300001000623us-gaap:MaterialReconcilingItemsMemberus-gaap:EmployeeSeveranceMember2024-07-012024-09-300001000623us-gaap:MaterialReconcilingItemsMemberus-gaap:EmployeeSeveranceMember2025-01-012025-09-300001000623us-gaap:MaterialReconcilingItemsMemberus-gaap:EmployeeSeveranceMember2024-01-012024-09-300001000623us-gaap:MaterialReconcilingItemsMemberus-gaap:OtherRestructuringMember2025-07-012025-09-300001000623us-gaap:MaterialReconcilingItemsMemberus-gaap:OtherRestructuringMember2024-07-012024-09-300001000623us-gaap:MaterialReconcilingItemsMemberus-gaap:OtherRestructuringMember2025-01-012025-09-300001000623us-gaap:MaterialReconcilingItemsMemberus-gaap:OtherRestructuringMember2024-01-012024-09-300001000623us-gaap:MaterialReconcilingItemsMember2025-07-012025-09-300001000623us-gaap:MaterialReconcilingItemsMember2024-07-012024-09-300001000623us-gaap:MaterialReconcilingItemsMember2025-01-012025-09-300001000623us-gaap:MaterialReconcilingItemsMember2024-01-012024-09-300001000623us-gaap:FacilityClosingMembermatv:FAMSegmentMember2025-07-012025-09-300001000623us-gaap:FacilityClosingMembermatv:FAMSegmentMember2024-07-012024-09-300001000623us-gaap:FacilityClosingMembermatv:FAMSegmentMember2025-01-012025-09-300001000623us-gaap:FacilityClosingMembermatv:FAMSegmentMember2024-01-012024-09-300001000623us-gaap:FacilityClosingMembermatv:FAMSegmentMember2025-09-300001000623us-gaap:FacilityClosingMembermatv:SASSegmentMember2024-07-012024-09-300001000623us-gaap:FacilityClosingMembermatv:SASSegmentMember2024-01-012024-09-300001000623us-gaap:LineOfCreditMembermatv:NewCreditFacilityRevolvingCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2025-09-300001000623us-gaap:LineOfCreditMembermatv:NewCreditFacilityRevolvingCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2024-12-310001000623us-gaap:LineOfCreditMembermatv:TermLoanFacilityAMemberus-gaap:SecuredDebtMember2025-09-300001000623us-gaap:LineOfCreditMembermatv:TermLoanFacilityAMemberus-gaap:SecuredDebtMember2024-12-310001000623us-gaap:LineOfCreditMembermatv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2025-09-300001000623us-gaap:LineOfCreditMembermatv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2024-12-310001000623us-gaap:LineOfCreditMembermatv:DelayedDrawTermLoanFacilityMemberus-gaap:SecuredDebtMember2025-09-300001000623us-gaap:LineOfCreditMembermatv:DelayedDrawTermLoanFacilityMemberus-gaap:SecuredDebtMember2024-12-310001000623matv:A8.000SeniorUnsecuredNotesDue2029Memberus-gaap:UnsecuredDebtMember2025-09-300001000623matv:A8.000SeniorUnsecuredNotesDue2029Memberus-gaap:UnsecuredDebtMember2024-12-310001000623matv:GermanLoanAgreementMemberus-gaap:MediumTermNotesMember2025-09-300001000623matv:GermanLoanAgreementMemberus-gaap:MediumTermNotesMember2024-12-310001000623us-gaap:LineOfCreditMembermatv:NewCreditFacilityMember2018-09-250001000623us-gaap:LineOfCreditMembermatv:NewCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2018-09-252018-09-250001000623us-gaap:LineOfCreditMembermatv:NewCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2018-09-250001000623us-gaap:LineOfCreditMembermatv:TermLoanFacilityAMemberus-gaap:SecuredDebtMember2018-09-252018-09-250001000623us-gaap:LineOfCreditMembermatv:TermLoanFacilityAMemberus-gaap:SecuredDebtMember2018-09-250001000623us-gaap:RevolvingCreditFacilityMembermatv:NewCreditFacilityMember2018-09-250001000623us-gaap:LineOfCreditMembermatv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2021-02-102021-02-100001000623us-gaap:LineOfCreditMembermatv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2021-02-100001000623us-gaap:LineOfCreditMembermatv:NewCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2022-05-060001000623us-gaap:LineOfCreditMembermatv:DelayedDrawTermLoanFacilityMemberus-gaap:SecuredDebtMember2022-05-060001000623us-gaap:LineOfCreditMemberus-gaap:FederalFundsEffectiveSwapRateMembermatv:TermLoanFacilityAMemberus-gaap:SecuredDebtMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembermatv:TermLoanFacilityAMemberus-gaap:SecuredDebtMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembermatv:TermLoanFacilityAMemberus-gaap:ScenarioPlanMembersrt:MinimumMemberus-gaap:SecuredDebtMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembermatv:TermLoanFacilityAMemberus-gaap:ScenarioPlanMembersrt:MaximumMemberus-gaap:SecuredDebtMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:BaseRateMembermatv:TermLoanFacilityAMemberus-gaap:ScenarioPlanMembersrt:MinimumMemberus-gaap:SecuredDebtMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:BaseRateMembermatv:TermLoanFacilityAMemberus-gaap:ScenarioPlanMembersrt:MaximumMemberus-gaap:SecuredDebtMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:FederalFundsEffectiveSwapRateMemberus-gaap:RevolvingCreditFacilityMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:BaseRateMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMemberus-gaap:BaseRateMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2022-07-052022-07-050001000623us-gaap:LineOfCreditMembermatv:SecuredOvernightFinancingRateSOFRFloorMembermatv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2023-07-012023-07-010001000623us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembermatv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2023-07-012023-07-010001000623us-gaap:LineOfCreditMembermatv:EuroInterbankOfferedRateEURIBORFloorMembermatv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2023-07-012023-07-010001000623us-gaap:LineOfCreditMembermatv:EuroInterbankOfferedRateEURIBORMembermatv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2023-07-012023-07-010001000623us-gaap:LineOfCreditMembermatv:NewCreditFacilityMember2023-12-300001000623matv:A8.000SeniorUnsecuredNotesDue2029Member2024-10-070001000623us-gaap:RevolvingCreditFacilityMembermatv:PreviousSeniorCreditFacilityMember2025-09-300001000623matv:TermLoanFacilityAMemberus-gaap:SecuredDebtMember2025-09-300001000623matv:TermLoanFacilityBMemberus-gaap:SecuredDebtMember2025-09-300001000623matv:DelayedDrawTermLoanFacilityMemberus-gaap:SecuredDebtMember2025-09-300001000623matv:NewCreditFacilityMember2025-01-012025-09-300001000623matv:NewCreditFacilityMember2024-01-012024-09-300001000623us-gaap:UnsecuredDebtMember2025-09-300001000623us-gaap:UnsecuredDebtMember2024-12-310001000623us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310001000623us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-09-300001000623us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2025-09-300001000623us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2024-12-310001000623us-gaap:ForeignExchangeContractMemberus-gaap:AccountsReceivableMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:AccountsPayableMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2025-09-300001000623us-gaap:InterestRateContractMemberus-gaap:AccountsReceivableMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-09-300001000623us-gaap:InterestRateContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-09-300001000623us-gaap:InterestRateContractMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-09-300001000623us-gaap:InterestRateContractMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:AccountsReceivableMemberus-gaap:NondesignatedMemberus-gaap:FairValueHedgingMember2025-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:FairValueHedgingMember2025-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:NondesignatedMember2025-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:AccountsReceivableMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-12-310001000623us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-12-310001000623us-gaap:ForeignExchangeContractMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-12-310001000623us-gaap:ForeignExchangeContractMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2024-12-310001000623us-gaap:InterestRateContractMemberus-gaap:OtherAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-12-310001000623us-gaap:InterestRateContractMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-12-310001000623us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310001000623us-gaap:ForeignExchangeContractMemberus-gaap:AccountsReceivableMemberus-gaap:NondesignatedMemberus-gaap:FairValueHedgingMember2024-12-310001000623us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:FairValueHedgingMember2024-12-310001000623us-gaap:FairValueHedgingMemberus-gaap:NondesignatedMember2024-12-310001000623us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-07-012025-09-300001000623us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001000623us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-09-300001000623us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001000623us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-07-012025-09-300001000623us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001000623us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-09-300001000623us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001000623us-gaap:DesignatedAsHedgingInstrumentMember2025-07-012025-09-300001000623us-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001000623us-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-09-300001000623us-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-07-012025-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:NondesignatedMember2025-07-012025-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:NondesignatedMember2024-07-012024-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:NondesignatedMember2025-01-012025-09-300001000623us-gaap:FairValueHedgingMemberus-gaap:NondesignatedMember2024-01-012024-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-07-012025-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-07-012024-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-01-012025-09-300001000623us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-012024-09-300001000623us-gaap:InterestRateSwapMember2025-01-012025-09-300001000623srt:MaximumMember2025-09-300001000623country:USus-gaap:UnionizedEmployeesConcentrationRiskMemberus-gaap:WorkforceSubjectToCollectiveBargainingArrangementsMember2025-01-012025-09-300001000623us-gaap:NonUsMemberus-gaap:UnionizedEmployeesConcentrationRiskMemberus-gaap:WorkforceSubjectToCollectiveBargainingArrangementsMember2025-01-012025-09-300001000623country:USus-gaap:UnionizedEmployeesConcentrationRiskMemberus-gaap:WorkforceSubjectToCollectiveBargainingArrangementsExpiringWithinOneYearMember2025-01-012025-09-300001000623us-gaap:NonUsMemberus-gaap:UnionizedEmployeesConcentrationRiskMemberus-gaap:WorkforceSubjectToCollectiveBargainingArrangementsExpiringWithinOneYearMember2025-01-012025-09-300001000623country:USus-gaap:PensionPlansDefinedBenefitMember2025-07-012025-09-300001000623country:USus-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300001000623us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2025-07-012025-09-300001000623us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300001000623country:USus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-07-012025-09-300001000623country:USus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012024-09-300001000623us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-07-012025-09-300001000623us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012024-09-300001000623country:USus-gaap:PensionPlansDefinedBenefitMember2025-01-012025-09-300001000623country:USus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001000623us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2025-01-012025-09-300001000623us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001000623country:USus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-09-300001000623country:USus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-09-300001000623us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2025-01-012025-09-300001000623us-gaap:ForeignPlanMemberus-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-09-300001000623us-gaap:OperatingSegmentsMember2025-07-012025-09-300001000623us-gaap:OperatingSegmentsMember2024-07-012024-09-300001000623us-gaap:OperatingSegmentsMember2025-01-012025-09-300001000623us-gaap:OperatingSegmentsMember2024-01-012024-09-30

 

(Commission file number)

(Exact name of registrant as specified in its charter) 

 

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   ☒     No   ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No  ☒

The Company had 54,681,114 shares of common stock outstanding as of November 3, 2025.

 

Organization and operations - Mativ Holdings, Inc. ("Mativ," "we," "our," or the "Company") is a global leader in specialty materials, solving our customers’ most complex challenges by engineering bold, innovative solutions that connect, protect, and purify our world. Mativ manufactures globally through our family of business-to-business and consumer product brands. Mativ targets premium applications across diversified and growing end-markets, from filtration to healthcare to sustainable packaging and more. Our broad portfolio of technologies combines polymers, fibers, and resins to optimize the performance of our customers’ products across multiple stages of the value chain.

The Engineered Papers business ("EP business"), sold in November 2023 (the "EP Divestiture"), is presented as a discontinued operation where applicable. The unaudited condensed consolidated financial statements and the notes thereto, unless otherwise indicated, are on a continuing operations basis.

Reportable Segments - the Company has two reportable segments: (1) Filtration & Advanced Materials ("FAM"), focused primarily on filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions ("SAS") focused primarily on tapes, labels, liners, specialty paper, packaging and healthcare solutions.

 

The accompanying unaudited condensed consolidated financial statements and the notes thereto have been prepared in accordance with the instructions on Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission ("SEC") and do not include all the information and disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). However, such information reflects all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of results for the interim periods.

 

The results of operations for the three and nine months ended September 30, 2025 are not necessarily indicative of the results to be expected for the full year. The unaudited condensed consolidated financial statements and these notes thereto included herein should be read in conjunction with the audited consolidated financial statements and the related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on February 27, 2025.

Selling expense and General expense prior year amounts in the Condensed Consolidated Statements of Income (Loss) have been reclassified to Selling and general expense and Intangible asset amortization expense to conform to the current year presentation for comparative purposes.

 

The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the revenues and expenses during the reporting period. Actual results could differ significantly from these estimates. The significant estimates underlying our unaudited condensed consolidated financial statements include, but are not limited to, inventory valuation, goodwill valuation, useful lives of tangible and intangible assets, equity-based compensation, derivatives, receivables valuation, pension, postretirement and other benefits, taxes and contingencies.

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." The amendment enhances reportable segment disclosure requirements, primarily regarding significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of other segment items and expanded interim disclosures that align with those required annually, among other provisions. The amendments in this ASU became effective on a retrospective basis for annual periods beginning January 1, 2024, and interim periods within those annual periods beginning January 1, 2025. The adoption of this standard is reflected in Note 14. Segment Information.

In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." The amendment enhances income tax disclosure requirements, particularly regarding the effective tax rate reconciliation and income taxes paid. The amendments in this ASU are effective for fiscal years beginning after December 15, 2024. The adoption of this accounting standard will not have an impact on our consolidated financial statements, but this standard will require certain additional disclosures.

In November 2024, the FASB issued ASU 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures." The ASU requires a public business entity to provide disaggregated disclosures of certain categories of expenses on an annual and interim basis including purchases of inventory, employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains those expenses. This ASU is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on the Company’s disclosures.

In July 2025, the FASB issued ASU 2025-05, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets." The ASU provide entities with a practical expedient to simplify the estimation of expected credit losses on current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606, Revenue from Contracts with Customers, by allowing the assumption that current conditions as of the balance sheet date will not change during the remaining life of the asset. The ASU is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements.

In September 2025, the FASB issued ASU 2025-06, "Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." The ASU modernizes existing internal use software guidance to adapt to concepts and processes present in an agile development environment. Key amendments include the elimination of software project development stages in favor of a requirement to commence capitalization once management has authorized the project, committed to funding, and project completion is probable. This ASU is effective for interim and annual reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements.

The Company recognizes revenues when control of a product is transferred to the customer. Control is transferred when the products are shipped from one of the Company’s manufacturing facilities to the customer. Any freight costs billed to and paid by a customer are included in Net sales. The cost the Company pays to deliver finished goods to our customers is recorded as a component of Cost of products sold. These costs include the amounts paid to a third party to deliver the finished goods.

Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied, which generally occurs when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services.

Generally, the Company considers collectability of amounts due under a contract to be probable upon inception of a sale based on an evaluation of the credit worthiness of each customer. If collectability is not considered to be probable, the Company defers recognition of revenue on satisfied performance obligations until the uncertainty is resolved. We record estimates for credit losses based on our expectations for the collectability of amounts due from customers, considering historical collections, expectations for future activity and other discrete events as applicable.

Variable consideration, such as discounts or price concessions, is set forth in the terms of the contract at inception and is included in the assessment of the transaction price at the outset of the arrangement. The transaction price is allocated to the individual performance obligations due under the contract based on the relative stand-alone fair value of the performance obligations identified in the contract. The Company typically uses an observable price to determine the stand-alone selling price for separate performance obligations.

The Company does not typically include extended payment terms or significant financing components in its contracts with customers. Certain sales contracts may include cash-based incentives (volume rebates or credits), which are accounted for as variable consideration. We estimate these amounts at least quarterly based on the expected forecast quantities to be provided to customers and adjust revenues recognized accordingly. Incidental items that are immaterial in the context of the contract are recognized as expense in the period incurred. The Company generally expenses sales commissions when incurred because the amortization period is one year or less. These costs are recorded within Selling and general expense. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less and contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed. As a practical expedient, the Company treats shipping and handling activities that occur after control of the good transfers as fulfillment activities, and therefore, does not account for shipping and handling costs as a separate performance obligation.

Net sales are attributed to the following geographic locations of the Company’s direct customers during the three months ended September 30, 2025 and 2024 were as follows (in millions):

Net sales are attributed to the following geographic locations of the Company’s direct customers during the nine months ended 2025 and 2024 were as follows (in millions):

Net sales as a percentage by product category for the business were as follows:

FAM is focused primarily on filtration media and components, advanced films, coating and converting solutions, and extruded mesh products. The FAM segment supplies customers directly, serving a diverse set of generally high-growth end markets.

Filtration & netting – includes high efficiency filtration media and components used in transportation applications, water filtration, industrial processes, life science, HVAC, and air pollution control, as well as extruded mesh products used in agriculture, and various packaging applications.

Advanced films – includes paint protection films used in the transportation aftermarket channel, optical films for glass and glazing applications, interlayer films and lamination for ballistic resistance, medical films and composites for advanced wound care and consumer products, security glass, high-performance graphic substrates, and emerging smart glass applications.

SAS is focused primarily on tapes, labels, liners, specialty paper, packaging and healthcare solutions. The SAS segment supplies customers through distribution and directly, serving growing and mature end markets.

Tapes, labels & liners – includes substrates for tapes used in building & construction, infrastructure, DIY, athletic, and industrial applications, substrates critical to protection and adhesive separation (including release liners and carriers) for applications in the personal care, label, tape, industrial, graphic arts, composites, and medical categories, as well as performance labels, and cable wrapping.

Paper & packaging – includes premium printing and other specialty papers and packaging applications used for print collateral, advertising, direct mail, product packaging, graphics, wallpaper, and education, as well as consumer office, stationery and craft papers sold to large retailers, for small business, personal use and educational applications.

Healthcare & other – includes advanced wound care, consumer wellness, device fixation, medical packaging, as well as a wide range of other solutions and applications.

On December 23, 2022, and further amended on October 20, 2023, the Company entered into an accounts receivables sales agreement (the "Receivables Sales Agreement") to sell certain trade receivables arising from revenue transactions of the Company's U.S. subsidiaries on a revolving basis. The maximum funding commitment of the Receivables Sales Agreement is $175.0 million. The agreement has an initial term of three years. On November 5, 2025, the Company entered into an amendment to the Receivable Sales Agreement to, among other things, (1) extend the term until November 5, 2026, and (2) reduce the maximum funding commitment from $175.0 million to $150.0 million.

In connection with the Receivables Sales Agreement, the Company formed a separate bankruptcy-remote special purpose entity ("SPE"), which is a wholly owned and controlled subsidiary. The Company continuously transfers receivables to the SPE and the SPE transfers ownership and control of certain receivables that meet certain qualifying conditions to a third-party financial institution in exchange for cash. Certain receivables are held by the SPE and are pledged to secure the collectability of the sold receivables.

The amount of receivables pledged as collateral as of September 30, 2025 and December 31, 2024 was $30.0 million and $28.7 million, respectively. The SPE incurs fees due to the third-party financial institution related to accounts receivable sales transactions.

The Company has continuing involvement with the receivables transferred by the SPE to the third-party financial institution by providing collection services.

The Company also participates in uncommitted trade accounts receivable sales programs ("Reverse Receivables Programs") under which certain trade receivables are sold, without recourse, to a third-party financial institution in exchange for cash. The Company does not retain any interest in or continuing involvement with the invoices after they are sold. The invoices are sold at face value, less a transaction fee.

The Company accounts for transactions under the Receivables Sales Agreement and Reverse Receivables Programs as sales of financial assets, with the associated receivables derecognized from the Company’s unaudited Condensed Consolidated Balance Sheets. Total fees related to the Receivables Sales Agreement and Reverse Receivables Programs are considered to be a loss on the sale of financial assets. Continuous cash activity related to the Receivables Sales Agreement and Reverse Receivables Programs is reflected in cash from operating activities in the unaudited Condensed Consolidated Statements of Cash Flows.

The following table summarizes the activity under the Receivables Sales Agreement and Reverse Receivables Programs (in millions):

Comprehensive loss includes Net loss, as well as items charged directly to stockholders' equity, which are excluded from Net loss. The Company has presented Comprehensive loss in the unaudited Condensed Consolidated Statements of Comprehensive Income (Loss). Reclassification adjustments of derivative instruments from Accumulated other comprehensive income, net of tax are presented in Other expense, net or Interest expense in the unaudited Condensed Consolidated Statements of Income (Loss). Refer to Note 10. Derivatives for additional information. Amortization of accumulated pension and other post-employment benefit ("OPEB") liabilities are included in the computation of net pension and OPEB costs, which are discussed in Note 12. Postretirement and Other Benefits.

Components of Accumulated other comprehensive income, net of tax, were as follows (in millions):

Changes in the components of Accumulated other comprehensive income, net of tax, were as follows (in millions):

The Company uses the two-class method to calculate Net loss per share. The Company has granted restricted stock that contains non-forfeitable rights to dividends on unvested shares. Since these unvested shares are considered participating securities under the two-class method, the Company allocates loss per share to common stock and participating securities according to dividends declared and participation rights in undistributed earnings.

Diluted net loss per common share is computed based on Net loss divided by the weighted average number of common and potential common shares outstanding. Potential common shares during the respective periods are those related to dilutive stock-based compensation, including long-term stock-based incentive compensation and directors’ accumulated deferred stock compensation, which may be received by the directors in the form of stock or cash.

A reconciliation of the average number of common and potential common shares outstanding used in the calculations of basic and diluted net loss per share follows (in millions, shares in thousands):

(1)Diluted loss per share excludes an immaterial amount of weighted average potential common shares for the three and nine months ended September 30, 2025 and 2024 as their inclusion would be anti-dilutive.

 

Inventories, net are valued at the lower of cost (using the first-in, first-out and weighted average methods) or net realizable value. The Company's costs included in inventory primarily include resins, pulp, chemicals, direct labor, utilities, maintenance, depreciation, finishing supplies and an allocation of certain overhead costs. Machine start-up costs or unplanned machine shutdowns are expensed in the period incurred and are not reflected in inventory. The Company reviews inventories at least quarterly to determine the necessity of write-offs for excess, obsolete or unsalable inventory. The Company estimates write-offs for inventory obsolescence and shrinkage based on its judgment of future realization. These reviews require the Company to assess customer and market demand. There were no material inventory write-offs during the three and nine months ended September 30, 2025 and 2024.

The following table summarizes inventories by major class (in millions):    

The changes in the carrying amount of goodwill by reportable segment were as follows (in millions):

Accumulated impairment loss for the FAM segment was $411.9 million as of September 30, 2025. Accumulated impairment loss for the SAS segment was $401.0 million as of September 30, 2025.

The fair value of a reporting unit is determined based on an income approach, utilizing estimated future cash flows discounted at a rate commensurate with the risk involved. This approach considers significant assumptions including projections of future performance, specifically our ability to sustain and grow market share at forecasted margins. It also includes significant assumptions regarding the rate a market participant would use to discount those cash flows. Changes in these assumptions could have a significant impact on the assessment of fair value. The fair value of each reporting unit was estimated using the income approach; however, management also evaluated the fair value under the market approach to ensure the reasonableness of the estimated fair values.

While significant estimates and assumptions related to forecasted future cash flows used in the March 1, 2025, interim impairment test were generally aligned with those used in the annual impairment test performed as of October 1, 2024, the discount rate for the FAM reporting unit which is aligned with the operating and reportable segment, was increased to 14%, to reflect a market participant view of additional risk associated with achieving forecasted cash flows in the growing end markets with which FAM is aligned. The interim impairment test resulted in a full impairment of all goodwill attributable to the FAM reporting unit.

The fair value of the SAS reporting unit, also aligned with the operating and reportable segment, was estimated to exceed its carrying value by approximately 6% as of March 1, 2025. Forecasted cash flows for SAS are primarily aligned with both growing and mature end markets, therefore it is subject to less risk than FAM. The interim impairment test for SAS utilized a discount rate and long-term growth rate of 10.5% and 2%, respectively.

The Company’s ability to achieve forecasted cash flows in SAS may be negatively impacted by factors including, but not limited to, deterioration of general economic conditions, seasonal or cyclical market and industry fluctuations, adverse changes in our end-market sectors, and the imposition of tariffs and other trade barriers.

The gross carrying amount and accumulated amortization for intangible assets as of September 30, 2025 consisted of the following (in millions):

The gross carrying amount and accumulated amortization for intangible assets as of December 31, 2024 consisted of the following (in millions):

Amortization expense of intangible assets was $16.0 million and $15.4 million for the three months ended September 30, 2025 and 2024, respectively, and $47.3 million and $46.9 million for the nine months ended September 30, 2025 and 2024, respectively. Intangibles are expensed using the straight-line amortization method.

 

In January 2024, we announced an organizational realignment initiative (the "Plan") that is expected to streamline organizational size and complexity and leverage business critical resources to enhance customer support and reduce overhead cost. Restructuring and other impairment expenses related to the Plan were comprised primarily of severance charges. Activities associated with a first wave of the Plan were completed during 2024, with additional initiatives expected through 2026. Restructuring activities associated with the current initiative are substantially complete; additional costs are not expected to be significant.

During the third quarter of 2025, we recognized an impairment charge of $4.7 million associated with long-lived assets at one of our North American facilities, which will be closed during the fourth quarter of 2025.

Assets held for sale of $5.0 million and $10.3 million were included in Other current assets as of September 30, 2025 and December 31, 2024, respectively.

The following table summarizes total restructuring and other impairment expense (in millions):